Migraine Frequency and Aura Impacts Sensory Organization
AbbVie Submits NDA for ABBV-951, Periconceptional Folic Acid Supplementation Lowers Preterm Birth Risk, FDA Accepts NDA for Zavegepant
NeurologyLive® Friday 5 — May 27, 2022
Neurology on the Hill 2022: Takeaways and Progress